Fig. 8From: Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancerEvaluation of drug sensitivity and immunotherapy. a, b Sensitivity analysis of chemotherapeutic drugs between different risk groups; c The relationship between five genes in the signature and the drug sensitivity; d The comparison of immunophenoscore (IPS) between different risk subgroupsBack to article page